Combination Therapy for COPD

• 收藏
• 分享

专利权人:

Chiese Farmaceutici S.p.A.

发明人:

Bonelli, Sauro,Usberti, Francesca,Zambelli, Enrico

申请号：

AU2016234895

公开号：

AU2016234895A1

申请日:

2016.09.27

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

#$%^&*AU2016234895A120161013.pdf#####ABSTRACT COMBINATION THERAPY FOR COPD The invention concerns an aerosol formulation suitable for 5 administering to COPD patients by means of a pressurized metered dose inhaler (pMDI), comprising glycopyrronium bromide in combination with formoterol. The formulation further comprises a HFA propellant, a co-solvent, and an amount of inorganic acid sufficient to stabilize both the glycopyrronium bromide and the formoterol components. Optionally the 10 formulation further comprises beclometasone dipropionate.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/